• citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:30
  • full-text downloads in 30 days:3


article: 6 from 26  
Back back to result list
2018, vol. 49, iss. 2, pp. 137-140
Advantages of percutaneous coronary intervention in relation to medication therapy in patients with stable angina pectoris ( three-wessel coronary disease)
aPHI 'Sv Vračevi' Bijeljina, Internal Department, Department of Interventional Cardiology, Bijeljina, BiH
bClinical Center of Serbia, Clinic for Cardiology, Belgrade
cClinic Center Kragujevac, Cardiology Clinic, Kragujevac
dPHI 'Sv Vračevi' Bijeljina, BiH
Patient, a man, age of 66 years, was admitted to the Internal Department, Interventional Cardiology Department for chest pains by type of stable angina pectoris. CCS II. In ambulatory conditions he was made non-invasive diagnostics, and after a positive ergometric test, a decision was made that the patient be admitted to the catheterization hall for invasive diagnosis and possible percutaneous coronary intervention.
Amoroso, G., van Boven, A.J., Crijns, H.J.G.M. (2001) Drug therapy or coronary angioplasty for the treatment of coronary artery disease: New insights. American Heart Journal, 141(2): S22-S25
Bucher, H. (2000) Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ, 321(7253): 73-77
Claude, J., Schindler, C., Kuster, G.M., Schwenkglenks, M., Szucs, T., Buser, P., Osswald, S., Kaiser, C., Grädel, C., Estlinbaum, W., Rickenbacher, P., Pfsterer, M. (2004) Cost effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease: Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME). Eur Heart J, 25, 2195-2203
Davies, R.F., Goldberg, A. D., Forman, S., Pepine, C.J., Knatterud, G.L., Geller, N., Sopko, G., Pratt, C., Deanfield, J., Conti, C. R. (1997) Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Two-Year Follow-up. Circulation, 95(8): 2037-2043
Hartigan, P.M., Giacomini, J.C., Folland, E.D., Parisi, A.F. (1998) Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). American Journal of Cardiology, 82(12): 1445-1450
Parisi, A.F., Folland, E.D., Hartigan, P. (1992) A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med, 326: 10-6
Pepine, C.J., Geller, N.L., Knatterud, G.L., Bourassa, M.G., Chaitman, B.R., Davies, R.F., Day, P., Deanfield, J.E., Goldberg, A., McMahon, R.P., Mueller, H., Ouyang, P., Pratt, C., Proschan, M. (1994) The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. Journal of the American College of Cardiology, 24(1): 1-10
Pfisterer, M. (2004) Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: Four-year follow-up of the randomized trial of invasive versus medical therapy in elderly patients (time). Circulation, 110(10): 1213
Pitt, B., Waters, D., Brown, W.V., van Boven, A.J., Schwartz, L., Title, L.M., Eisenberg, D., Shurzinske, L., McCormick, L.S. (1999) Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med, 341(2): 70-6
The RITA-2 trial participants (1997) Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet, 350(9076): 461-468


article language: English
document type: Case Report
DOI: 10.7251/SCMED1802137M
published in SCIndeks: 14/02/2019

Related records

Arhiv za farmaciju (2003)
Ostojić Miodrag Č., et al.

Materia medica (2008)
Percutaneous coronary intervention in the elderly patient
Aleksić Aleksandar

Medicus (2005)
Atorvastatin: Efficacy in atherosclerosis and cardiovascular disease with emphasis to atherogenesis
Beleslin Dušan B., et al.

show all [4]